Weekly docetaxel versus docetaxel/gemcitabine in elderly/poor performance status (PS) patients (pts) with stage IIIB/IV non-small cell lung cancer (NSCLC): Randomized phase III trial of the Minnie Pearl Cancer Research Network

被引：0
|
作者：
Greco, F. A.
Spigel, D. R.
Burris, H. A., III
Shipley, D. L.
Farley, C.
Gandhi, J.
Houston, G. A.
Hainsworth, J. D.
机构：
[1] Tennessee Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[2] Associates Oncol & Hematol, Chattanooga, TN USA
[3] Jackson Oncol Associates, Jackson, MS USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7534
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Phase ii trial with Docetaxel in patients (PTS) with non small cell lung cancer (NSCLC)
    Latreille, J
    Laberge, F
    Viallet, J
    Maksymiuk, A
    Shepherd, F
    Gelman, K
    Delorme, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1070 - 1070
  • [22] Weekly administration of gemcitabine plus docetaxel in advanced non-small cell lung cancer (NSCLC).
    Sun, Y
    Li, J
    Wu, Y
    Li, L
    Gu, L
    Zhang, L
    Wang, J
    Zhang, X
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 698S - 698S
  • [23] Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
    Georgoulias, Vassilis
    Androulakis, Nikolaos
    Kotsakis, Athanasios
    Hatzidaki, Dora
    Syrigos, Kostas
    Polyzos, Aris
    Agelidou, Athina
    Varthalitis, Loannis
    Ziras, Nikoalos
    Agelidou, Maria
    Chandrinos, Vassilis
    Boukovinas, Loannis
    Geroyianni, Alexandra
    Vamakas, Larnbros
    Mavroudis, Dirnitris
    LUNG CANCER, 2008, 59 (01) : 57 - 63
  • [24] Docetaxel plus carboplatin versus docetaxel for the patients with old age or poor performance in advanced non-small cell lung cancer: randomized phase III study
    Kang, Byung Woog
    Lee, Dae Ho
    Suh, Cheolwon
    Lee, Jung Shin
    Choi, Chang Min
    Tae-Sun, Shim
    Kim, Woo-Sung
    Hong, Jeong Sook
    Sang-We, Kim
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S546 - S546
  • [25] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Preliminary results of a phase II trial of Docetaxel (D) and Gemcitabine (G) in advanced Non-Small Cell Lung Cancer (NSCLC) in elderly and/or unfit patients (PTS)
    Buffoni, Lucio
    Grillo, Raffaella
    Barone, Carla
    Dongiovanni, Diego
    Gaspari, Fabio
    Giacobino, Alice
    Consito, Lorena
    Ciuffreda, Libero
    Schena, Marina
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S668 - S668
  • [27] Results of a Phase II study of weekly docetaxel and carboplatin in stage IIIB (with effusion) or stage IV non-small cell lung cancer patients age ≤65 and performance status 2
    Weissman, CH
    Sandbach, J
    Brooker, R
    Vellek, M
    Lindquist, D
    Conkling, P
    Llegbodu, D
    Asmar, L
    LUNG CANCER, 2006, 52 (03) : 313 - 317
  • [28] Phase II study of weekly docetaxel and gemcitabine in relapsed patients (pts) with advanced, platinum-exposed non-small cell lung cancer (NSCLC)
    Langer, C. J.
    Huang, C.
    Ruth, K.
    Shafer, D.
    Borghaei, H.
    Millenson, M.
    Mintzer, D.
    Staddon, A.
    Seldomridge, J.
    Tuttle, H.
    Treat, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [29] A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly
    Leong, Swan Swan
    Toh, Chee Keong
    Lim, Wan Teck
    Lin, Xu
    Tan, Say Beng
    Poon, Donald
    Tay, Miah Hiang
    Foo, Kian Fong
    Ho, Juliana
    Tan, Eng Huat
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (03) : 230 - 236
  • [30] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III randomized trial
    Georgoulias, V.
    Ardavanis, A.
    Tsiafaki, X.
    Agelidou, A.
    Syrigos, K.
    Polyzos, A.
    Kakolyris, S.
    Kouroussis, Ch
    Androulakis, N.
    Chatzidaki, D.
    ANNALS OF ONCOLOGY, 2004, 15 : 169 - 169
12345